News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
166 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32063)
Month
January (3098)
February (3516)
March (3513)
April (3269)
May (4089)
June (3205)
July (2932)
August (3176)
September (2859)
October (3385)
November (3129)
December (2245)
Day
1 (166)
2 (150)
5 (178)
6 (226)
7 (210)
8 (247)
9 (209)
12 (216)
13 (177)
14 (155)
15 (161)
16 (92)
19 (125)
20 (129)
21 (97)
26 (129)
27 (119)
28 (112)
29 (137)
30 (94)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
26
27
28
29
30
Drug Development
Sanofi (France) and Regeneron Pharmaceuticals, Inc. Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
November 1, 2012
·
9 min read
Business
Cell Therapeutics, Inc. (CTI) Reduces Net Loss for Third Quarter and Nine Months Ended September 30, 2012 Compared to Same Periods in 2011
November 1, 2012
·
1 min read
Business
Watson Pharmaceuticals, Inc. Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
November 1, 2012
·
1 min read
Biotech Bay
Amarantus BioSciences, Inc. Explores Orphan Drug Strategy Based on MANF Protein Folding
November 1, 2012
·
4 min read
Lone Star Bio
ULURU Inc. Release: Management to Invest on the Same Terms as Melmed Holdings AG
November 1, 2012
·
1 min read
Deals
SRS Medical Systems Acquires the Spanner&™ Prostatic Stent From AbbeyMoor Medical, Inc., the First and Only FDA Cleared Temporary Stent for the Male Urethra
November 1, 2012
·
2 min read
Drug Development
Optimer Pharmaceuticals, Inc. Initiates Phase 3b Clinical Trial of DIFICID® for the Prevention of Clostridium difficile-Associated Diarrhea in Bone Marrow Transplant Patients
November 1, 2012
·
6 min read
Biotech Bay
Agilent Technologies Inc. Introduces Game-Changing Solution for Advanced Liquid Handling and Sample-Preparation Automation
November 1, 2012
·
1 min read
Drug Development
Phase III Data Show Greater Compliance Across Demographic Groups With Agile Therapeutics, Inc.’ Contraceptive Patch Compared to an Oral Contraceptive
November 1, 2012
·
3 min read
Lone Star Bio
Cyberonics Inc. to Report Fiscal Year 2013 Second Quarter Results And Host Webcast And Conference Call On November 16, 2012
November 1, 2012
·
1 min read
Previous
3 of 17
Next